Investigating Behavior Change Methods for the Management of Hypertension
2 other identifiers
interventional
37
1 country
1
Brief Summary
This project aims to promote general wellness using a mobile health intervention that incorporates health coaching to help manage hypertension. The mobile application (HyperCoach) does not intend to cure, mitigate, or prevent hypertension. The main questions it aims to answer are:
- 1.Does digital mobile health coaching impact hypertension management outcomes, including blood pressure and adherence?
- 2.How does adherence to mobile health intervention influence the long-term man-agement and outcomes of hypertension?
- 3.How are health beliefs and QOL affected by digital coaching and health tracking for hypertension management?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Aug 2023
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 31, 2023
CompletedFirst Submitted
Initial submission to the registry
April 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
June 8, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedJune 8, 2026
April 1, 2026
2.8 years
April 14, 2026
June 1, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Baseline Systolic Blood Pressure
Blood pressure was measured by participants using a blood pressure cuff.
From enrollment to Day 90 and 270 of the intervention.
Change in Baseline Diastolic Blood Pressure
Blood pressure was measured by the participants using blood pressure cuffs.
From enrollment to the end of the treatment at Day 90 and 270.
Secondary Outcomes (10)
Changes from Baseline Weight to Study Conclusion from Baseline to Day 90 and Day 270
From enrollment to the end of treatment at 90 days and 270 days.
Change from Quality of Life (SF-36) Score from Baseline to Day 90 and Day 270
Surveys will be completed on enrollment, day 90, and day 270 of the study.
Change in Health Belief Analysis Score from Baseline to Day 90 and Day 270
Surveys will be completed at enrollment, on day 90, and on day 270 of the study.
Changes in Technology Acceptance Model Score from Baseline to Day 90 and Day 270
Surveys will be completed at enrollment, on day 90, and on day 270 of the study.
Changes in Dual Factor Models from Baseline to Day 90 and Day 270
Surveys will be completed at enrollment, on day 90, and on day 270 of the study.
- +5 more secondary outcomes
Study Arms (2)
Digital Coaching
EXPERIMENTALA study will be conducted where participants will be guided through a 90-day hypertension AHA-approved care plan, and 180-days later, will be checked for self-sustainability. The coaching plan that has been developed was created through AHA-approved content and guidelines. The participants will be provided with a blood pressure cuff and a weight scale. The iPhone application will provide the coaching group participants with a combination of educational content and motivational messages.
Health Awareness
ACTIVE COMPARATORThe Health Awareness group will only receive daily reminders to complete their measurements, the ability to track, and display their data trends in a graph.
Interventions
The participants will have the opportunity to establish their own personal health goals for blood pressure, resting heart rate, weight, and step count in HyperCoach. At the end of every week, participants will have the opportunity to have a progress report available to them to demonstrate their current trends regarding their weight, blood pressure, resting heart rate, and step count. The progress report will also allow users to change their current goals to more appropriate ones according to their health and knowledge development. The participants will be provided with a Bluetooth-enabled blood pressure cuff and weight scale. The devices will be used alongside the participants' IOS phones to collect their blood pressure and weight readings through the use of the iPhone Application - HyperCoach. The application will provide the participants with American Heart Association (AHA) approved content in the form of flyers, messages, and videos.
Daily reminders to monitor bloodp pressure and weight , mobile platform functions are disabled except for biofeedback and trend graphs.
Eligibility Criteria
You may qualify if:
- Reliable internet access for mobile device (either WIFI or mobile data plan)
- iOS (14+) smarthphone (iPhone 6S or newer)
- Fluent in English or Spanish
- Participant is taking hypertension medication
- Diagnosis is hypertension
- + years of age
You may not qualify if:
- Diagnosed with resistant hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas A&M University
College Station, Texas, 77843, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 14, 2026
First Posted
June 8, 2026
Study Start
August 31, 2023
Primary Completion
June 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
June 8, 2026
Record last verified: 2026-04